Microbio Co., Ltd. (TPEX: 4128)

Market Cap	19.44B
Revenue (ttm)	1.68B
Net Income (ttm)	-873.89M
Shares Out	588.17M
EPS (ttm)	-1.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,231,756
Open	33.65
Previous Close	33.60
Day's Range	33.05 - 33.80
52-Week Range	31.38 - 49.33
Beta	1.37
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 7, 2025

About Microbio

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is base...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2000
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4128